ClinicalTrials.Veeva

Menu

Cardiometabolic Disease Risk Factors in Cameroon (URBACAM-D)

Johns Hopkins University logo

Johns Hopkins University

Status

Invitation-only

Conditions

Cardiac Disease
Metabolic Disease

Treatments

Diagnostic Test: Cardiometabolic disease

Study type

Observational

Funder types

Other

Identifiers

NCT06957548
IRB00474444

Details and patient eligibility

About

Cardiometabolic diseases (CMDs) are a major public health concern in sub-Saharan Africa, including Cameroon. Studies have shown a significant increase in the prevalence of hypertension, diabetes, and obesity in recent years. However, access to timely diagnosis and treatment remains limited, particularly in rural areas. Community-based screening programs have been shown to be effective in identifying individuals with undiagnosed CMD risk factors and promoting early intervention. By leveraging the strengths of community-based approaches, the URBACAM-D study aims to address the growing burden of CMDs in urban Cameroon.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Screening is open to any adult over the age of 18 years

Trial contacts and locations

1

Loading...

Central trial contact

Dimitri Tito, DO

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems